3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Colonic Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Paclitaxel
31
Cyclophosphamide
25
Trastuzumab
23
Doxorubicin
17
Docetaxel
15
Carboplatin
15
pembrolizumab
13
Radiotherapy
11
Letrozole
11
Capecitabine
11
exemestane
10
Fulvestrant
10
Magnetic Resonance Spectroscopy
8
Lapatinib
8
Biopsy
8
eribulin
7
abemaciclib
7
Taxes
7
Bevacizumab
7
Anastrozole
7
pertuzumab
6
palbociclib
6
Neoadjuvant Therapy
6
Goserelin
6
Drug Therapy
6
Aromatase Inhibitors
6
130-nm albumin-bound paclitaxel
6
Therapeutics
5
Saline Solution
5
Radiosurgery
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Doxycycline
×
Breast
×
Clear all
NCT02201381
2022-07-18
METRICS
Health Clinics Limited
Phase 3
Withdrawn